Working… Menu

Aripiprazole (Abilify®) as an Adjunctive Treatment for Inadequate Response in Major Depressive Disorder

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01696617
Recruitment Status : Completed
First Posted : October 1, 2012
Last Update Posted : April 9, 2019
Otsuka Pharmaceutical Co., Ltd.
Information provided by (Responsible Party):
Yong Min Ahn, Seoul National University Hospital

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : December 2016
Actual Study Completion Date : February 2019